Anticancer drug delivery with nanoparticles

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 697-702

  Conti, Matteo ^a,b   Tazzari, Valeria ^a,b   Baccini, Cesare ^a,b   Pertici, Gianni ^c   Serino, Lorenzo Pio ^c   De Giorgi, Ugo ^d  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Dipartimento di Onco Ematologia   (Italy)

Author keywords

Drug deliver; Liposomes; Loco regional delivery; Nanomedicine; Nanoparticles; Nanotechnology; Review; Toxicity

Indexed keywords

2DEVINYL 2 (1 HEXYLOXYETHYL)PYROPHEOPHORBIDE; ACLACINOMYCIN; ALBUMIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CHITOSAN; DENDRIMER; DEXTRAN; DOXORUBICIN; DRUG CARRIER; FLUORESCEIN; GELATIN; GOLD; HIGH DENSITY LIPOPROTEIN; LIPOSOME; LOW DENSITY LIPOPROTEIN; MACROGOL; METHOTREXATE; NANOPARTICLE; PACLITAXEL; PHOTOSENSITIZING AGENT; POLYLACTIC ACID; POLYMER; QUANTUM DOT; SILICON DIOXIDE; TRITIUM; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BREAST CANCER; CANCER CHEMOTHERAPY; CERAMICS; CYTOTOXICITY; DIAGNOSTIC PROCEDURE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; EMULSION; FLUORESCENCE ANALYSIS; GENE TARGETING; HUMAN; IMMUNOPATHOLOGY; MAGNETIC FIELD; MALIGNANT NEOPLASTIC DISEASE; MYCOSIS; NANOENCAPSULATION; NANOMEDICINE; NANOTECHNOLOGY; PARTICLE SIZE; PHAGOCYTE; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; REVIEW; SOLID TUMOR; TUMOR CELL; VIRUS CAPSID;

EID: 33846096021     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Arciola CR, Bustanji Y, Conti M et al: Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials 24(18): 3013-3019, 2003.
2. Bustanji Y, Arciola CR, Conti M, Mandello E, Montanaro L and Samori B: Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc Natl Acad Sci USA 100(23): 13292-13297, 2003.
3. Moghimi SM, Hunter AC and Murray JC: Nanomedicine: current status and future prospects. Faseb J 19(3): 311-330, 2005.
4. Barratt G: Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci 60(1): 21-37, 2003.
5. Schmitt-Sody M, Strieth S, Krasnici S et al: Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin Cancer Res 9(6): 2335-2341, 2003.
6. Shukla GS and Krag DN: Selective delivery of therapeutic agents for the diagnosis and treatment of cancer. Expert Opin Biol Ther 6(1): 39-54, 2006.
7. Cegnar M, Kristl J and Kos J: Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours. Expert Opin Biol Ther 5(12): 1557-1569, 2005.
8. Yih TC and Al-Fandi M: Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 97(6): 1184-1190, 2006.
9. Editorial: Nanomedicine: a matter of rhetoric? Nat Mater 5(4): 243, 2006.
10. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M and Nie S: Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 13(1): 40-46, 2002.
11. Gao X, Chan WC and Nie S: Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt 7(4): 532-537, 2002.
12. Gao X, Cui Y, Levenson RM, Chung LW and Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22(8): 969-976, 2004.
13. Michalet X, Pinaud FF, Bentolila LA et al: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709): 538-544, 2005.
14. Drummond DC, Zignani M and Leroux J: Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 39(5): 409-460, 2000.
15. Panyam J, Zhou WZ, Prabha S, Sahoo SK and Labhasetwar V: Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb J 16(10): 1217-1226, 2002.
16. Clark HA, Hoyer M, Philbert MA and Kopeiman R: Optical nanosensors for chemical analysis inside single living cells. 1. Fabrication, characterization, and methods for intracellular delivery of PEBBLE sensors. Anal Chem 71(21): 4831-4836, 1999.
17. Jain KK: Nanoparticles as targeting ligands. Trends Biotechnol 24(4): 143-145, 2006.
18. Farrer RA, Butterfield FL, Chert VW and Fourkas JT: Highly efficient multiphoton-absorption-induced luminescence from gold nanoparticles. Nano Lett 5(6): 1139-1142, 2005.
19. Paciotti GF, Myer L Weinreich D et al: Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11(3): 169-183, 2004.
20. Ozkan M: Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discov Today 9(24): 1065-1071, 2004.
21. Choi Y and Baker JR Jr: Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer. Cell Cycle 4(5): 669-671, 2005.
22. Kukowska-Latallo JF, Candido KA, Cao Z et al: Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65(12): 5317-5324, 2005.
23. Yang YY, Wang Y, Powell R and Chan P: Polymeric core-shell nanoparticles for therapeutics. Clin Exp Pharmacol Physiol 33(5-6): 557-562, 2006.
24. Revets H, De Baetselier P, Muyldermans S: Nanobodies as novel agents for cancer therapy. Expert Opin Biol Ther 5(1): 111-124, 2005.
25. Lou B, Liao XL, Wu MP, Cheng PF, Yin CY and Fei Z: High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J Gastroenterol 11(7): 954-959, 2005.
26. Weissleder R, Kelly K, Sun EY, Shtatland T and Josephson L: Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23(11): 1418-1423, 2005.
27. Jordan A, Scholz R, Maier-Hauff K et al: The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78(1): 7-14, 2006.
28. Alexiou C, Schmid RJ, Jurgons R et al: Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J 35(5): 446-450, 2006.
29. Zou Y, Fu H, Ghosh S, Farquhar D and Klostergaard J: Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clin Cancer Res 10(21): 7382-7391, 2004.
30. Brannon-Peppas L and Blanchette JO: Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11): 1649-1659, 2004.
31. Roy I, Ohulchanskyy TY, Pudavar HE et al: Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125(26): 7860-7865, 2003.
32. Lee LJ: Polymer nano-engineering for biomedical applications. Ann Biomed Eng 34(1): 75-88, 2006.
33. Lu Z, Yeh TK, Tsai M, Au JL and Wientjes MG: Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 10(22): 7677-7684, 2004.
34. Abraxis Oncology: Abraxane prescribing information. http://www.abraxane.com
35. Pluen A, Boucher Y, Ramanujan S et al: Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci USA 98(8): 4628-4633, 2001.
36. Jain RK: Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46(1-3): 149-168, 2001.
37. Hunter AC and Moghimi SM: Therapeutic synthetic polymers: a game of Russian roulette? Drug Discov Today 7(19): 998-1001, 2002.
38. Shvedova AA, Castranova V, Kisin ER et al: Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 66(20): 1909-1926, 2003.
39. LaVan DA, Lynn DM and Langer R: Moving smaller in drug discovery and delivery. Nat Rev Drug Discov 1(1): 77-84, 2002.